Bringing Brigatinib to Neurofibromatosis Type-2 Patients: From...

Children’s Tumor Foundation and Takeda Pharmaceuticals Launch INTUITT for NF2 in Partnership with 6 Leading Medical Centers(PRWeb May 29, 2020)Read the full story at https://www.prweb.com/releases/bringing_brigatinib_to_neurofibromatosis_type_2_patients_from_promising_potential_to_platform_clinical_trial/prweb17157522.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news